Brean Digs Into Osiris Therapeutics 10Q, Downgrades To Sell By: Benzinga via Benzinga November 17, 2015 at 08:16 AM EST Osiris Therapeutics, Inc. (NASDAQ: OSIR) shares are down 19 percent in the last three months, even after hitting a high at $21.13 ... Read More >> Related Stocks: Osiris Therapeutics Stryker Corp